Works matching DE "PANCREATIC cancer"

Results: 5000
    1
    2
    3
    4
    5

    Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial.

    Published in:
    OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2014.1001217
    By:
    • Schmitz-Winnenthal, Friedrich H;
    • Weitz, Jürgen;
    • Ulrich, Alexis;
    • Buechler, Markus W;
    • Pianka, Frank;
    • Klaiber, Ulla;
    • Diener, Markus;
    • Leowardi, Christine;
    • Schimmack, Simon;
    • Sisic, Leila;
    • Keller, Anne-Valerie;
    • Koc, Ruhan;
    • Knebel, Philipp;
    • Schmidt, Thomas;
    • Hohmann, Nicolas;
    • Mikus, Gerd;
    • Haefeli, Walter E;
    • Niethammer, Andreas G;
    • Breiner, Klaus M;
    • Friedrich, Tobias
    Publication type:
    Article
    6

    CD4 T cells potently induce epithelial-mesenchymal-transition in premalignant and malignant pancreatic ductal epithelial cells–novel implications of CD4 T cells in pancreatic cancer development.

    Published in:
    OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2014.1000083
    By:
    • Goebel, Lisa;
    • Grage-Griebenow, Evelin;
    • Gorys, Artur;
    • Helm, Ole;
    • Genrich, Geeske;
    • Lenk, Lennart;
    • Sebens, Susanne;
    • Wesch, Daniela;
    • Ungefroren, Hendrik;
    • Freitag-Wolf, Sandra;
    • Sipos, Bence;
    • Röcken, Christoph;
    • Schäfer, Heiner
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Molecular pathology of early pancreatic cancer.

    Published in:
    Cancer Biomarkers, 2011, v. 9, n. 1-6, p. 421
    By:
    • Srivastava, Sudhir;
    • Grizzle, William E.;
    • Remmers, Neeley;
    • Bailey, Jennifer M.;
    • Mohr, Ashley M.;
    • Hollingsworth, Michael A.
    Publication type:
    Article
    19
    20
    21

    Multianalyte profiling of serum cytokines for detection of pancreatic cancer.

    Published in:
    Cancer Biomarkers, 2005, v. 1, n. 6, p. 259, doi. 10.3233/CBM-2005-1601
    By:
    • Zeh, H. J.;
    • Winikoff, S.;
    • Landsittel, D. P.;
    • Gorelik, E.;
    • Marrangoni, A. M.;
    • Velikokhatnaya, L.;
    • Winans, M. T.;
    • Lee, K.;
    • Moser, A.;
    • Bartlett, D.;
    • Lotze, M. T.;
    • Siegfried, J. M.;
    • Whitcomb, D.;
    • Slivka, A.;
    • Bigbee, W. L.;
    • Lokshin, A. E.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28

    A phase 1 dual‐dose escalation study of radiation and nab‐paclitaxel in patients with unresectable and borderline resectable pancreatic cancer.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 12, p. 1, doi. 10.1002/cncr.35936
    By:
    • Amit, Uri;
    • Metz, James M.;
    • Plastaras, John P.;
    • Gheewala, Rohi;
    • Teitelbaum, Ursina;
    • Damjanov, Nevena;
    • Vollmer, Charles;
    • Schneider, Charles J.;
    • Lee, Major Kenneth;
    • O'Hara, Mark;
    • Reiss‐Binder, Kim;
    • Carpenter, Erica L.;
    • Karasic, Thomas B.;
    • Konski, Andre;
    • Wileyto, E. Paul;
    • Ben‐Josef, Edgar
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Transcriptomic analysis of laser-capture microdissected tumors reveals RAD51AP1 as a tumor-specific marker associated progression from pancreatic intraepithelial neoplasia to invasive pancreatic cancer.

    Published in:
    Cancer Cell International, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12935-025-03810-1
    By:
    • Rezagholizadeh, Fereshteh;
    • Salimi, Adel;
    • Sharifi-Zarchi, Ali;
    • Azmoudeh-Ardalan, Farid;
    • Mousavizadeh, Kazem;
    • Tajik, Fatemeh;
    • Mahshid, Panahi;
    • Khorramdelazad, Hossein;
    • Wadji, Masoud Baghai;
    • Kashanizadeh, Atefeh;
    • Lotfalizadeh, Alireza;
    • Javad Mowla, Seyed;
    • Joghataei, Mohammad Taghi
    Publication type:
    Article